4.7 Article

G0-G1 Transition and the Restriction Point in Pancreatic β-Cells In Vivo

Journal

DIABETES
Volume 63, Issue 2, Pages 578-584

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/db12-1035

Keywords

-

Funding

  1. Juvenile Diabetes Research Foundation
  2. National Institutes of Health (Beta Cell Biology Consortium)
  3. Israel Cancer Research Fund (Barbara Goodman PC-RCDA)
  4. European Union (European Research Council) [241883]
  5. Leona M. and Harry B. Helmsley Charitable Trust
  6. Dutch Friends of Hebrew University
  7. I-CORE Program of the Planning and Budgeting Committee
  8. Israel Science Foundation [41.11]

Ask authors/readers for more resources

Most of our knowledge on cell kinetics stems from in vitro studies of continuously dividing cells. In this study, we determine in vivo cell-cycle parameters of pancreatic -cells, a largely quiescent population, using drugs that mimic or prevent glucose-induced replication of -cells in mice. Quiescent -cells exposed to a mitogenic glucose stimulation require 8 h to enter the G(1) phase of the cell cycle, and this time is prolonged in older age. The duration of G(1), S, and G(2)/M is approximate to 5, 8, and 6 h, respectively. We further provide the first in vivo demonstration of the restriction point at the G(0)-G(1) transition, discovered by Arthur Pardee 40 years ago. The findings may have pharmacodynamic implications in the design of regenerative therapies aimed at increasing -cell replication and mass in patients with diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available